Table 2.
Number of individual FLCs that contain detectable globin mRNA, and Cts for each analysis | ||||
---|---|---|---|---|
Culture conditions | α: P = ns | α: Ct mean (± SD), range | βH1: P < .005 | βH1: Ct mean (± SD), range |
Ins/EPO | 15/15 | 24.4 (± 5.3), 19.5-35.6 | 0/15 | 40.0 (± 0), 40.0 |
BIE | 15/15 | 23.4 (± 2.2), 20.5-28.4 | 11/15 | 36.3 (± 3.0), 32.4-40 |
Individual eFLCs were tested for both α and βH1 globin gene expression. α-globin gene expression was detectable in all cells; βH1 was detectable in most (11/15) eFLCs that had been treated with ins/EPO and SCFAs, but not (0/15) in eFLCs treated only with ins/EPO (P < .005). Mean cycle threshold (Ct) for α- and βH1-globin gene analysis of cDNA real-time polymerase chain reaction (PCR) are also shown.
FLC indicates fetal liver cell; Ins, insulin; EPO, erythropoietin; BIE, butyrate plus ins/EPO; and eFLC, erythroid fetal liver cell.